About
Technology
Issues
FAQ
Links
Official Page
Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2, multicentre study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.